Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A five-year experience with central nervous system lymphoma.

D Kotasek, L E Albertyn, R E Sage

    The Medical Journal of Australia
    |March 17, 1986
    PubMed
    Summary

    This study reports on central nervous system (CNS) non-Hodgkin's lymphoma cases diagnosed between 1979-1983. The incidence was 4.5%, with varied findings on computer-assisted tomographic scans.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)<sup>☆</sup>.

    Annals of oncology : official journal of the European Society for Medical Oncology·2021
    Same author

    Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2020
    Same author

    Early and late changes in markers of aortic stiffness with breast cancer therapy.

    Internal medicine journal·2014
    Same author

    A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanoma.

    British journal of cancer·2009
    Same author

    An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy.

    Annals of oncology : official journal of the European Society for Medical Oncology·2007
    Same author

    Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer.

    British journal of cancer·2007

    Area of Science:

    • Neurology
    • Oncology
    • Radiology

    Background:

    • Central nervous system (CNS) non-Hodgkin's lymphoma is a rare but serious condition.
    • Understanding its incidence and presentation is crucial for diagnosis and treatment.

    Purpose of the Study:

    • To report the experience with CNS non-Hodgkin's lymphoma over a five-year period.
    • To describe the clinical, pathological, and neuroradiological findings.
    • To highlight the varied appearances on computer-assisted tomographic (CT) scans.

    Main Methods:

    • Retrospective review of 222 patients with non-Hodgkin's lymphoma.
    • Identification of 10 new CNS lymphoma cases (primary and secondary).
    • Analysis of clinical, pathological, and neuroradiological data, including CT scans.

    Main Results:

    • An overall incidence of 4.5% for CNS non-Hodgkin's lymphoma was observed.
    • Eight secondary and two primary CNS lymphoma cases were diagnosed.
    • Diverse presentations were noted on CT scans, emphasizing the need for careful interpretation.

    Conclusions:

    • CNS non-Hodgkin's lymphoma presented with varied imaging characteristics.
    • Accurate diagnosis relies on integrating clinical, pathological, and neuroradiological findings.
    • CT scan interpretation requires awareness of the spectrum of appearances in CNS lymphoma.

    Related Experiment Videos